Medifast (MED) Long-Term Deferred Tax (2017 - 2025)

Medifast has reported Long-Term Deferred Tax for 9 years, with the latest figure at $12.1 million in Q3 2025.

• For the quarter ending Q3 2025, Long-Term Deferred Tax rose 202.55% year-over-year to $12.1 million; the trailing twelve-month figure through Sep 2025 stood at $12.1 million (up 202.55% YoY), and the FY2024 full-year result was $11.5 million, up 178.36% from the prior year.
• Long-Term Deferred Tax for Q3 2025 stood at $12.1 million, up from $11.5 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $12.1 million in Q3 2025, with the low at $692000.0 in Q1 2021.
• Historically, Long-Term Deferred Tax has averaged $5.8 million across 5 years, with a median of $4.4 million in 2021.
• Annual changes were most pronounced in 2021 — Long-Term Deferred Tax plunged 66.59% — and 2022, when it jumped 788.73%.
• Medifast's Long-Term Deferred Tax stood at $4.4 million in 2021, then advanced by 20.98% to $5.3 million in 2022, then dropped by 22.73% to $4.1 million in 2023, then surged by 178.36% to $11.5 million in 2024, then gained by 5.65% to $12.1 million in 2025.
• The last three Long-Term Deferred Tax figures came in at $12.1 million (Q3 2025), $11.5 million (Q2 2025), and $11.4 million (Q1 2025), per Business Quant data.